301 related articles for article (PubMed ID: 17544512)
1. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.
Kemp S; Wheate NJ; Buck DP; Nikac M; Collins JG; Aldrich-Wright JR
J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512
[TBL] [Abstract][Full Text] [Related]
2. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
3. Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.
Fisher DM; Bednarski PJ; Grünert R; Turner P; Fenton RR; Aldrich-Wright JR
ChemMedChem; 2007 Apr; 2(4):488-95. PubMed ID: 17340669
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
5. Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles.
Wheate NJ; Taleb RI; Krause-Heuer AM; Cook RL; Wang S; Higgins VJ; Aldrich-Wright JR
Dalton Trans; 2007 Nov; (43):5055-64. PubMed ID: 17992290
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
9. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
Yoshida M; Khokhar AR; Siddik ZH
Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
[TBL] [Abstract][Full Text] [Related]
10. Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione.
Kemp S; Wheate NJ; Pisani MJ; Aldrich-Wright JR
J Med Chem; 2008 May; 51(9):2787-94. PubMed ID: 18412325
[TBL] [Abstract][Full Text] [Related]
11. DNA interaction of platinum(II) complexes with 1,10-phenanthroline and extended phenanthrolines.
Cusumano M; Di Pietro ML; Giannetto A
Inorg Chem; 2006 Jan; 45(1):230-5. PubMed ID: 16390060
[TBL] [Abstract][Full Text] [Related]
12. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
[TBL] [Abstract][Full Text] [Related]
13. meso-[{Ru(phen)2}2(mu-HAT)]4+: a high-affinity DNA hairpin probe {HAT = 1,4,5,8,9,12-hexaazatriphenylene; phen = 1,10-phenanthroline}.
Smith JA; Morgan JL; Turley AG; Collins JG; Keene FR
Dalton Trans; 2006 Jul; (26):3179-87. PubMed ID: 16802035
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.
Kemp S; Wheate NJ; Wang S; Collins JG; Ralph SF; Day AI; Higgins VJ; Aldrich-Wright JR
J Biol Inorg Chem; 2007 Sep; 12(7):969-79. PubMed ID: 17653578
[TBL] [Abstract][Full Text] [Related]
15. Role of carrier ligand in platinum resistance in L1210 cells.
Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG
Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) complexes with antitumoral/antiviral aromatic heterocycles: effect of glutathione upon in vitro cell growth inhibition.
Papadia P; Margiotta N; Bergamo A; Sava G; Natile G
J Med Chem; 2005 May; 48(9):3364-71. PubMed ID: 15857142
[TBL] [Abstract][Full Text] [Related]
17. Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition.
Ma G; Huang F; Pu X; Jia L; Jiang T; Li L; Liu Y
Chemistry; 2011 Oct; 17(41):11657-66. PubMed ID: 21910144
[TBL] [Abstract][Full Text] [Related]
18. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs.
Roy S; Hagen KD; Maheswari PU; Lutz M; Spek AL; Reedijk J; van Wezel GP
ChemMedChem; 2008 Sep; 3(9):1427-34. PubMed ID: 18537202
[TBL] [Abstract][Full Text] [Related]
19. Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir.
Margiotta N; Bergamo A; Sava G; Padovano G; de Clercq E; Natile G
J Inorg Biochem; 2004 Aug; 98(8):1385-90. PubMed ID: 15271515
[TBL] [Abstract][Full Text] [Related]
20. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
